PPARG and Cognitive impairment: Consistently, Xiang et al. [34] indicated that PPARγ agonist, pioglitazone, exerts a significant neuroprotective effect against scopolamine-induced cholinergic system deficit and cognitive impairment by significantly decreasing the escape latency.